🧬Over 17K Commercial Antibodies Have Problematic Image Manipulations
Researchers find image manipulation in over 17,000 antibodies
TL;DR
A Northwestern University post-doc discovered that images used to market commercial antibodies were manipulated. Over 17,500 antibodies from 16 companies showed signs of manipulation, impacting lab reliability and research integrity.
In May, a post-doc at Northwestern University uncovered image manipulations in over 17,500 commercially available antibodies from 16 different companies. The manipulations ranged from adjusting brightness/contrast to copying data to fabricate results. Researchers relying on these images may waste time and resources troubleshooting issues that stem from faulty antibody performance rather than their own procedures. This discovery highlights the need for rigorous validation of lab tools, impacting thousands of research projects worldwide.
Key Points
Over 17,500 commercial antibodies from 16 companies showed signs of image manipulation in May.
Manipulations included adjusting brightness/contrast and copying/pasting data to fabricate results.
Researchers may waste time troubleshooting issues due to unreliable antibody performance.
The discovery impacts thousands of research projects worldwide using these antibodies.
Companies selling antibodies range from dismissing the issue to promising further investigation.
Why It Matters
If you're a researcher relying on commercial antibodies, this affects your lab's reliability. Over 17,500 antibodies show signs of image manipulation, leading to wasted time and resources troubleshooting issues that aren't with your procedures but with the antibody itself.
Frequently Asked Questions
Why does this matter?
If you're a researcher relying on commercial antibodies, this affects your lab's reliability. Over 17,500 antibodies show signs of image manipulation, leading to wasted time and resources troubleshooting issues that aren't with your procedures but with the antibody itself.
What happened?
A Northwestern University post-doc discovered that images used to market commercial antibodies were manipulated. Over 17,500 antibodies from 16 companies showed signs of manipulation, impacting lab reliability and research integrity.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,315 builders reading daily.